Apnea Test for Brain Death: Respiratory Therapist Overview
An educational overview of the RT's role during the apnea test component of brain death determination — prerequisites, oxygenation, monitoring, and safety considerations.
For educational reference only. Procedural and clinical management information on this page is intended for educational context only. Procedures must be performed by qualified, credentialed professionals following physician orders, institutional protocols, and competency requirements.
See also: RTB2 Medical Disclaimer · Editorial Policy
What Is the Apnea Test?
The apnea test is one component of the clinical determination of brain death (death by neurologic criteria). It tests for the absence of brainstem-mediated respiratory drive in a patient who meets clinical prerequisites for brain death evaluation. During the test, mechanical ventilation is temporarily discontinued to allow PaCO₂ to rise to a threshold level that would normally drive spontaneous breathing in any patient with intact brainstem function.
If the patient does not initiate any spontaneous respiratory effort when PaCO₂ reaches the target threshold (typically ≥60 mmHg, with an increase of ≥20 mmHg above baseline), the absence of respiratory drive is documented as consistent with brain death.
The respiratory therapist's role in the apnea test is typically:
- Managing the patient's oxygenation before, during, and after the test
- Adjusting ventilator settings during the prerequisite preparation phase
- Monitoring SpO₂ and assisting with serial ABG draws
- Managing airway safety throughout the test duration
- Promptly reconnecting the patient to the ventilator if abort criteria are met
- Documenting respiratory observations
Prerequisites Before the Apnea Test
Numerous physiologic prerequisites must be met before the apnea test can be safely performed. These are confirmed by the physician team, but the RT contributes to achieving them:
Core temperature ≥36°C
Hypothermia significantly depresses brainstem function and can mimic brain death. The patient must be normothermic before testing. Active warming may be required.
Hemodynamic stability
Systolic BP ≥100 mmHg (or per institutional protocol). Vasopressor support is acceptable but the patient must be hemodynamically stable. Extreme hemodynamic instability may preclude safe testing.
Normal sodium and glucose
Severe metabolic derangements (hyponatremia, hyperglycemia) can impair brainstem function and confound the test.
Absence of residual sedative, paralytic, or toxic drug effects
No confounding CNS depressants should be present. Time since last dose, drug half-lives, and renal/hepatic function are relevant factors.
Adequate baseline PaCO₂
The pre-test PaCO₂ should be in the normal range (35–45 mmHg). Patients with chronic CO₂ retention require adjustment of the target end-test PaCO₂.
Adequate oxygenation
SpO₂ ≥95%, PaO₂ ≥200 mmHg on FiO₂ 1.0 and PEEP 5 cmH₂O before the test begins — ensuring oxygenation reserve for the apneic period.
Oxygenation Methods During the Test
During the apnea test, the patient is disconnected from the ventilator and must receive passive oxygenation to maintain SpO₂ while PaCO₂ rises. Without oxygenation, severe hypoxemia would develop rapidly, making the test unsafe.
Common oxygenation methods during the apnea test:
T-piece with 100% oxygen
A T-piece (or Briggs adapter) connected to 10–12 L/min of 100% oxygen is attached to the ETT or tracheostomy. Passive flow of oxygen maintains oxygenation during the apneic period. This is the simplest and most widely used method.
CPAP with 100% oxygen
CPAP of 10 cmH₂O with FiO₂ 1.0 can be provided during the test. This has the theoretical advantage of maintaining alveolar recruitment. The ventilator must be configured to provide CPAP without triggering mandatory breaths — any ventilator-provided breath would invalidate the test.
Continuous intratracheal oxygen insufflation
An oxygen catheter is inserted into the ETT to the level of the carina, delivering 6–12 L/min of oxygen. Less commonly used but described in some protocols.
Monitoring During the Test
Continuous monitoring throughout the apnea test is mandatory:
- Continuous pulse oximetry — SpO₂ monitoring with immediate response to desaturation
- Continuous ECG — cardiac arrhythmias from autonomic changes are possible
- Continuous blood pressure monitoring — invasive arterial line preferred
- Clinical observation of the chest and abdomen for any respiratory movement
- Arterial blood gas: typically at the end of the test (or after 8–10 minutes) to confirm target PaCO₂ has been reached
What constitutes respiratory effort: any observed movement of the thorax or abdomen that appears to represent inspiratory effort is documented. Even minimal, ineffective effort is clinically significant and should be reported to the physician.
Abort Criteria
The apnea test must be immediately aborted and the patient reconnected to the ventilator if any of the following occur:
Physician Direction and Legal Protocol
Brain death determination is a legal process with significant ethical weight and legal consequences. Protocols vary by state law, institution, and patient population (adult vs. pediatric). The respiratory therapist's role is to support the physician team — never to independently determine brain death or to deviate from the institutional protocol.
Key RT responsibilities from a professional standpoint:
- Follow the institutional brain death protocol exactly — no improvisation.
- Document RT observations factually and objectively.
- Communicate clearly and promptly with the physician team throughout the test.
- Ensure the family is not present in the room during the test unless the institution specifically allows it.
- Treat the patient with full dignity and professionalism throughout.
Reviewed by RTB2 Editorial Team
Last updated April 2026